N

Northwest Arkansas Clinical Trials Center | Rogers, AR

Research site

(Unclaimed)

Location

597 Horsebarn Road #200, Rogers, Arkansas, United States of America

Site insights

Top conditions

Top treatments

LY3041658

CTP-543

Eltrekibart

ME3183

Patidegib

Sofpironium Bromide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

This study aims to find the appropriately safe and effective dose and dosing frequency for eltrekibart in adults with moderate-to-severe hidradenitis...

Enrolling

Hidradenitis Suppurativa

Drug: Placebo

Drug: Eltrekibart

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

The aim of this clinical study is to find out how well Patidegib Gel 2% works in preventing new basal cell carcinomas (BCCs) developing on the face o...

Enrolling

Gorlin Syndrome

Drug: Patidegib Topical Gel with no active patidegib

Drug: Patidegib Topical Gel

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...

Active, not recruiting

Alopecia Areata

Drug: CTP-543